Working as a Manufacturing Associate

At Amgen, there is no choice but better.  Because going halfway will never get us to tomorrow. We’re transforming the promise of science and biotechnology into therapies that have the power to restore health. We leverage our global talent—22,000 scientists and professionals—to research, manufacture and deliver new medicines and reach millions of patients worldwide. Amgen is an equal opportunity employer and will consider all qualified applicants for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, or disability status. See our Community Guidelines: http://bit.ly/smcgl

With over 85 years of serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance, and ensuring reliable global clinical and commercial product supply. Catalent employs over 15,000 people, including over 2,400 scientists and technicians, at more than 45 facilities, and in fiscal year 2020 generated over $3 billion in annual revenue. Catalent is headquartered in Somerset, NJ.

Bristol Myers Squibb is a global biopharmaceutical company committed to creating innovative medicines for millions of patients around the world fighting serious diseases in therapeutic areas such as oncology, hematology, immunology, cardiovascular and neuroscience. At the same time, we also nurture our own team with inspiring work and challenging career options. Bristol Myers Squibb is led by our unique BioPharma strategy that combines the innovation and agility of a biotech with the reach and resources of a major pharma company. Through our R&D organization, we have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate our work. As global citizens, through the Bristol Myers Squibb Foundation, we promote health equity and strive to improve health outcomes of populations disproportionately affected by serious diseases and conditions, giving new hope to some of the world’s most vulnerable people.

Our global team of more than 125,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

GSK is a global biopharma company with a special purpose – to unite science, technology and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organisation where people can thrive. Getting ahead means preventing disease as well as treating it, and we aim to impact the health of 2.5 billion people around the world in the next 10 years. NOTICE: Salary ranges on this site are estimates provided by Glassdoor and have not been verified by GSK. GSK Recruiters will share the salary range during the Recruitment process.

Lonza is a preferred global partner to the pharmaceutical, biotech and nutrition markets. We work to enable a healthier world by supporting our customers to deliver new and innovative medicines that help treat a wide range of diseases. We achieve this by combining technological insight with world-class manufacturing, scientific expertise and process excellence. Our business is structured to meet our customers' complex needs across four divisions: Biologics, Small Molecules, Cell & Gene and Capsules & Health Ingredients. Our unparalleled breadth of offerings across divisions enables our customers to commercialize their discoveries and innovations in the healthcare industry. Founded in 1897 in the Swiss Alps, today, Lonza operates across five continents. With approximately 17,500 employees (full-time equivalent), we comprise high-performing teams and individual talent who make a meaningful difference to our own business, as well as to the communities in which we operate. The company generated sales of CHF 6.2 billion with a CORE EBITDA of CHF 2.0 billion in Full-Year 2022.

At Lockheed Martin, we don’t just think big thoughts. We get things done. And we're bringing together the best minds in the industry to do it. From our Advanced Development Programs, also known as the Skunk Works® to advances in renewable energy, we're always adapting, always innovating, and always figuring out ways to meet the needs of the real challenges our customers face. If you're ready to solve problems that don't have quick answers, check us out.

Founded in 1978, Biogen is a leading global biotechnology company that has pioneered multiple breakthrough innovations including a broad portfolio of medicines to treat multiple sclerosis, the first approved treatment for spinal muscular atrophy, and two co-developed treatments to address a defining pathology of Alzheimer’s disease. Biogen is advancing a pipeline of potential novel therapies across neurology, neuropsychiatry, specialized immunology and rare diseases and remains acutely focused on its purpose of serving humanity through science while advancing a healthier, more sustainable and equitable world.

Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company. Rooted in over 240 years of distinguished history, our pursuit of potentially life-changing treatments for patients is what drives us forward today. We bring together the unique and diverse talents of a global team to deliver highly innovative medicines and transformative care to people around the world.

Dexcom Corporation (NASDAQ DXCM) is a pioneer and global leader in continuous glucose monitoring (CGM). Since 1999, Dexcom has developed innovative technology that has transformed how people manage diabetes. Dexcom has done this through sensor and software innovation to meet the unique needs of people with diabetes, their caregivers, and health care professionals. Dexcom has also led innovative advocacy work to ensure CGM technology can be accessible for more people around the world. As we look to our future, we envision an opportunity to help a much larger population. In 2022, motivated by evidence supporting broader use of glucose sensing technology, we magnified our mission: Empowering people to take control of their health. Our commitment to people with diabetes has not wavered. But as we contemplate our future, we are challenging our employees and stakeholder to embrace bigger possibilities for our best-in-class glucose sensing technology. We see a world in which our care for customers includes not only the treatment of chronic conditions, but the potential prevent the onset of disease by contributing to better overall health. At Dexcom we are guided by four core values: Listen, Think Big, Be Dependable, and Serve with Integrity.